Search clinical trials for: Propagermanium

Total 4 results

Dimerix Bioscience Pty Ltd
Iqvia Pty Ltd

Completed

Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan (ACTION)

Diabetic Kidney Disease

Australia
Dimerix Bioscience Pty Ltd
Iqvia Pty Ltd

Completed

Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan (ACTION)

Focal Segmental Glomerulosclerosis

Australia
Dimerix Bioscience Pty Ltd

Recruiting

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB (ACTION3)

FSGS

United States, Argentina, Australia, Denmark, France, Hong Kong, New Zealand, Spain, Taiwan, United Kingdom, Brazil
University of Sydney
The George Institute for Global Health, India

Terminated

Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19 (CLARITY 2)

COVID-19 | SARS-CoV2 Infection

India

3

Subscribe